Annual Financials for Option Care Health Inc.
Fiscal year is January-December. All values USD millions. |
2015 | 2016 | 2017 | 2018 | 2019 |
5-year trend |
Sales/Revenue
|
982.22M | 935.59M | 817.19M | 1.94B | 2.31B | |
Sales Growth |
- | -4.75% | -12.66% | 137.37% | 19.11% | |
Cost of Goods Sold (COGS) incl. D&A |
744.05M | 695.53M | 575.67M | 1.56B | 1.85B | |
COGS excluding D&A |
721.31M | 673.51M | 547.95M | 1.51B | 1.77B | |
Depreciation & Amortization Expense |
22.74M | 22.03M | 27.73M | 41.06M | 77.59M | |
Depreciation |
17.64M | 15.83M | 15.93M | 21.46M | 51.49M | |
Amortization of Intangibles |
5.1M | 6.2M | 11.8M | 19.6M | 26.1M | |
COGS Growth |
- | -6.52% | -17.23% | 170.23% | 18.99% | |
Gross Income |
238.17M | 240.06M | 241.52M | 384.15M | 459.31M | |
Gross Income Growth |
- | 0.79% | 0.61% | 59.06% | 19.56% | |
Gross Profit Margin |
- | - | - | - | 19.88% | NA |
|
2015 | 2016 | 2017 | 2018 | 2019 |
5-year trend |
SG&A Expense |
249.56M | 235.19M | 226.6M | 345.88M | 432.45M | |
Research & Development |
- | - | - | - | - | |
Other SG&A |
249.56M | 235.19M | 226.6M | 345.88M | 432.45M | |
SGA Growth |
- | -5.76% | -3.65% | 52.64% | 25.03% | |
Other Operating Expense |
- | - | - | - | - | |
Unusual Expense |
276.26M | 5.41M | 29.7M | (228,000) | 32.98M | |
EBIT after Unusual Expense |
(276.26M) | (5.41M) | (14.78M) | 228,000 | (6.12M) | |
Non Operating Income/Expense |
- | 3.95M | (581,000) | (2.16M) | (1.52M) | |
Non-Operating Interest Income |
- | - | - | - | - | |
Equity in Affiliates (Pretax) |
- | - | - | 1.02M | 2.84M | |
Interest Expense |
37.31M | 37.57M | 52.07M | 46.12M | 73.39M | |
Interest Expense Growth |
- | 0.69% | 38.59% | -11.42% | 59.12% | |
Gross Interest Expense |
37.31M | 37.57M | 52.07M | 46.12M | 73.39M | |
Interest Capitalized |
- | - | - | - | - | |
Pretax Income |
(324.96M) | (34.16M) | (67.43M) | (8.77M) | (78.19M) | |
Pretax Income Growth |
- | 89.49% | -97.42% | 87.00% | -791.81% | |
Pretax Margin |
- | - | - | - | -3.38% | NA |
Income Tax |
(21.53M) | 2.02M | (4.13M) | (2.65M) | (2.27M) | |
Income Tax - Current Domestic |
(76,000) | (30,000) | (751,000) | 1.18M | 2.07M | |
Income Tax - Current Foreign |
- | - | - | - | - | |
Income Tax - Deferred Domestic |
(21.46M) | 2.05M | (3.38M) | (3.83M) | (4.35M) | |
Income Tax - Deferred Foreign |
- | - | - | - | - | |
Income Tax Credits |
- | - | - | - | - | |
Equity in Affiliates |
- | - | - | - | - | |
Other After Tax Income (Expense) |
- | - | - | - | - | |
Consolidated Net Income |
(303.43M) | (36.17M) | (63.3M) | (6.12M) | (75.92M) | |
Minority Interest Expense |
- | - | - | - | - | |
Net Income |
(303.43M) | (36.17M) | (63.3M) | (6.12M) | (75.92M) | |
Net Income Growth |
- | 88.08% | -75.01% | 90.34% | -1,141.54% | |
Net Margin Growth |
- | - | - | - | -3.29% | NA |
Extraordinaries & Discontinued Operations |
3.72M | (6.59M) | (893,000) | - | - | |
Extra Items & Gain/Loss Sale Of Assets |
(11.42M) | - | - | - | - | |
Cumulative Effect - Accounting Chg |
- | - | - | - | - | |
Discontinued Operations |
15.15M | (6.59M) | (893,000) | - | - | |
Net Income After Extraordinaries |
(299.71M) | (42.77M) | (64.2M) | (6.12M) | (75.92M) | |
Preferred Dividends |
9.81M | 9.08M | 10.08M | - | - | |
Net Income Available to Common |
(298.09M) | (51.85M) | (74.27M) | (6.12M) | (75.92M) | |
EPS (Basic) |
(17.35) | (2.20) | (2.40) | (0.04) | (0.49) | |
EPS (Basic) Growth |
- | 87.32% | -9.09% | 98.21% | -1,032.40% | |
Basic Shares Outstanding |
17.18M | 23.44M | 30.95M | 142.61M | 156.28M | |
EPS (Diluted) |
(17.35) | (2.20) | (2.40) | (0.04) | (0.49) | |
EPS (Diluted) Growth |
- | 87.32% | -9.09% | 98.21% | -1,032.40% | |
Diluted Shares Outstanding |
17.18M | 23.44M | 30.95M | 142.61M | 156.28M | |
EBITDA |
11.35M | 26.9M | 42.65M | 79.32M | 104.44M | |
EBITDA Growth |
- | 136.94% | 58.57% | 86.00% | 31.67% | |
EBITDA Margin |
- | - | - | - | 4.52% | NA |